Dr. Reddy's Vows $320 Million, Four-Year Investment in Biologic Drugs
This article was originally published in PharmAsia News
Executive Summary
Dr. Reddy's Laboratories is looking to the future beyond generics drugs to develop biologic and proprietary medicines backed by a $320 million investment over the next four years.